Wroclaw, Poland

Ewelina Wincza


 


Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Ewelina Wincza: Innovating in Kinase Inhibitors**

Introduction

Ewelina Wincza is an accomplished inventor based in Wroclaw, Poland. With a strong focus on biomedical innovations, she holds two significant patents related to benzimidazole derivatives as kinase inhibitors. Her work contributes to the advancement of therapies for various diseases, highlighting her dedication and expertise in the field.

Latest Patents

Ewelina's latest patents concern the development of benzimidazole derivatives that act as kinase inhibitors. These inventions are crucial in the pharmaceutical domain as they provide novel therapeutic options for treating diseases linked to specific kinases, such as leukemias, lymphomas, solid tumors, and autoimmune disorders. The patented compounds demonstrate promising potential in targeting serine/threonine and tyrosine kinases, particularly PIM1-3 and DYRK1A, which are significant in disease pathology.

Career Highlights

Ewelina currently works with Selvita S.A., a prominent company noted for its innovation in the biotechnology sector. Her role involves extensive research and development to enhance therapeutic strategies involving kinase inhibitors. Wincza's contributions are valuable in translating scientific discoveries into viable medical applications, thus impacting patient outcomes positively.

Collaborations

Throughout her career, Ewelina has collaborated with notable professionals in her field, including Wojciech Czardybon and Krzysztof Brzózka. These partnerships underline the importance of teamwork in advancing scientific research and developing new solutions to complex health challenges.

Conclusion

Ewelina Wincza stands out as a remarkable inventor in the realm of kinase inhibitors. Her patents not only showcase her ingenuity but also play a significant role in the ongoing quest for effective treatments of serious health conditions. As she continues her work at Selvita S.A., her contributions are sure to influence future developments in biomedical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…